tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Strategic Advancements and Expanding Coverage Propel Plus Therapeutics’ Growth Potential
PremiumRatingsStrategic Advancements and Expanding Coverage Propel Plus Therapeutics’ Growth Potential
21d ago
Plus Therapeutics’ assay secures national coverage agreement with Humana
Premium
The Fly
Plus Therapeutics’ assay secures national coverage agreement with Humana
22d ago
Plus Therapeutics Gains Nasdaq Extension for Compliance
Premium
Company Announcements
Plus Therapeutics Gains Nasdaq Extension for Compliance
25d ago
Plus Therapeutics Signs Lease Agreement in Houston
PremiumCompany AnnouncementsPlus Therapeutics Signs Lease Agreement in Houston
2M ago
Plus Therapeutics provides update on CNSide Diagnostic platform launch
Premium
The Fly
Plus Therapeutics provides update on CNSide Diagnostic platform launch
2M ago
PSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Plus Therapeutics announces accreditation, certification for CNSide Diagnostics
PremiumThe FlyPlus Therapeutics announces accreditation, certification for CNSide Diagnostics
3M ago
Plus Therapeutics upgraded to Buy from Hold at D. Boral Capital
Premium
The Fly
Plus Therapeutics upgraded to Buy from Hold at D. Boral Capital
3M ago
Plus Therapeutics regains compliance with applicable Nasdaq listing criteria
Premium
The Fly
Plus Therapeutics regains compliance with applicable Nasdaq listing criteria
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100